In a recent paper using a tamoxifen-inducible p16 reporter mouse, LSECs were the most positive cells for p16, and the depletion of these cells ameliorated steatosis and inflammation in a NASH model [144]. The gene discussed is CDKN2A; the disease is steatosis.